BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8611939)

  • 1. [Comparison of the effects of fenticonazole and econazole on the aspartic proteinase secreted by Candida albicans].
    De Bernardis F; Cassone A
    Contracept Fertil Sex; 1996 Feb; 24(2):163-5. PubMed ID: 8611939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antimycotics on secretory acid proteinase of Candida albicans.
    Angiolella L; De Bernardis F; Bromuro C; Mondello F; Ceddia T; Cassone A
    J Chemother; 1990 Feb; 2(1):55-61. PubMed ID: 2185347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP.
    Milewski S; Mignini F; Covelli I; Borowski E
    J Med Vet Mycol; 1994; 32(1):1-11. PubMed ID: 8207618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro anti-fungal activity of the econazole-ornidazole combination (1:10 ratio)].
    Piccolomini R; Arpini A; Cellini L; Pagano M
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):257-61. PubMed ID: 6639779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytological study of the action of imidazoles on Candida albicans (author's transl)].
    Bastide M; Jouvert S; Bastide JM
    Pathol Biol (Paris); 1982 Jun; 30(6):458-62. PubMed ID: 7050853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of econazole by Warburg assay; comparison with other antimicrobials.
    Raab W; Gmeiner B
    Mykosen; 1976 Jul; 19(7):238-40. PubMed ID: 790175
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis.
    Lian CH; Liu WD
    Mycoses; 2007 Sep; 50(5):383-90. PubMed ID: 17714358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro.
    Tariq VN; Scott EM; McCain NE
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2615-9. PubMed ID: 8592989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans.
    Schaller M; Krnjaic N; Niewerth M; Hamm G; Hube B; Korting HC
    J Med Microbiol; 2003 Mar; 52(Pt 3):247-249. PubMed ID: 12621090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases.
    Borg-von Zepelin M; Meyer I; Thomssen R; Würzner R; Sanglard D; Telenti A; Monod M
    J Invest Dermatol; 1999 Nov; 113(5):747-51. PubMed ID: 10571729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
    Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
    Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Aspartic Proteases in Candida Virulence. Protease Inhibitors against Candida Infections.
    Monika S; Małgorzata B; Zbigniew O
    Curr Protein Pept Sci; 2017; 18(10):1050-1062. PubMed ID: 27514853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida albicans secreted aspartyl proteinases.
    Hube B
    Curr Top Med Mycol; 1996 Dec; 7(1):55-69. PubMed ID: 9504059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural products inhibiting Candida albicans secreted aspartic proteases from Tovomita krukovii.
    Zhang Z; ElSohly HN; Jacob MR; Pasco DS; Walker LA; Clark AM
    Planta Med; 2002 Jan; 68(1):49-54. PubMed ID: 11842327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Econazole effects on Trichophyton rubrum and Candida albicans--electron microscopic and cytochemical studies.
    Preusser HJ; Rostek H
    Mykosen Suppl; 1978; 1():314-21. PubMed ID: 400880
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of Candida albicans extracellular enzyme activity by selected natural substances and their application in Candida infection.
    Yordanov M; Dimitrova P; Patkar S; Saso L; Ivanovska N
    Can J Microbiol; 2008 Jun; 54(6):435-40. PubMed ID: 18535628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of virulence, pathogenicity, and itraconazole resistance with SAP activity in Candida albicans strains.
    Feng W; Yang J; Pan Y; Xi Z; Qiao Z; Ma Y
    Can J Microbiol; 2016 Feb; 62(2):173-8. PubMed ID: 26751517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
    Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the antifungal activity of fenticonazole on strains of Candida albicans on cellular lines.
    Cusumano V; Costa AL; Veronese M
    Mykosen; 1985 May; 28(5):238-43. PubMed ID: 3892289
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifungal efficiency of miconazole and econazole and the interaction with transport protein: a comparative study.
    Hu Z; Zhang J; Cheng X
    Pharm Biol; 2015 Feb; 53(2):251-61. PubMed ID: 25376919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.